Nippon India Pharma Fund Overview
Category Pharma Fund
BMSMONEY Rank -
BMSMONEY Rating
Gro. Opt. As On: 20-12-2024
NAV ₹512.96(R) -0.9% ₹568.38(D) -0.9%
Returns 1Y 3Y 5Y 7Y 10Y
LumpSum (R) 36.47% 20.9% 27.67% 20.24% 15.44%
LumpSum (D) 37.71% 21.99% 28.83% 21.31% 16.47%
SIP (R) -25.74% 25.84% 23.71% 23.3% 19.11%
SIP (D) -24.99% 27.01% 24.84% 24.4% 20.12%
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
0.78 0.42 0.73 2.57% 0.13
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
15.23% -14.68% -16.86% 0.9 10.49%
Top Pharma Fund
Fund Name Rank Rating
Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund -
Sbi Healthcare Opportunities Fund -
Dsp Healthcare Fund -
Tata India Pharma & Healthcare Fund -
Uti Healthcare Fund -

NAV Date: 20-12-2024

Scheme Name NAV Rupee Change Percent Change
NIPPON INDIA PHARMA FUND - IDCW Option 130.6
-1.1800
-0.9000%
NIPPON INDIA PHARMA FUND - DIRECT Plan - IDCW Option 182.17
-1.6500
-0.9000%
Nippon India Pharma Fund-Growth Plan-Growth Option 512.96
-4.6500
-0.9000%
Nippon India Pharma Fund-Growth Plan-Bonus Option 512.96
-4.6500
-0.9000%
Nippon India Pharma Fund - Direct Plan Growth Plan - Bonus Option 568.38
-5.1400
-0.9000%
Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option 568.38
-5.1400
-0.9000%

Review Date: 20-12-2024

A review of the different performance parameters of the fund is as follows:
  1. Returns: It signifies the growth in the investment's value over a specific period, presented either as a percentage or a monetary figure. Our analysis focused on six return parameters of this fund. The return parameters have been categorized into three performance groups: the top 25%, those below the top 25% but above average, and those below average. Now, let's take a look at how each parameter has performed.
    1. Top 25%: The fund does not have any return parameter in the top 25% in the category.
    2. Above Average Below the Top 25%: The fund does not have any return parameter which is above average but below the top 25%.
    3. Below Average: Six return parameters of the fund are below average in the category, which are listed below:
      • 1Y Return %
      • 5Y Return %
      • 3Y Return %
      • 6M Return %
      • 1M Return %
      • 3M Return %
  2. Risk: It signifies the potential for financial loss or the failure to achieve anticipated returns due to diverse elements. We have analyzed two risk parameters of Nippon India Pharma Fund, and divided it into three groups the lowest 25%, below average but above the lowest 25%, and above average. More details are provided below.
    1. Lowest 25%: Nippon India Pharma Fund does not have any risk parameters in the lowest 25% of the category. It means high risk compared to other funds in the category.
    2. Below Average but Above the Lowest 25%: Nippon India Pharma Fund has two risk parameters that are below average but above the lowest 25% in the category. These are:
      • Standard Deviation: It is a measure of the dispersion of a set of data from its mean. It is calculated as the square root of variance by determining the variation between each data point relative to the mean. The higher the standard deviation, the greater the risk. The standard deviation of the fund is 15.23 %.
      • Semi-Deviation: It is a measure of the dispersion of a set of data from its mean. It is calculated as the square root of variance by determining the variation between each data point relative to the mean. The higher the semi-deviation, the greater the risk. The semi-deviation of the fund is 10.49 %.
    3. Above Average: Nippon India Pharma Fund does not have any risk parameters above average; which is a good sign.
  3. Risk Adjusted Performance Parameters: Risk-adjusted performance parameters in mutual funds are parameters that assess the return on investments based on the risks involved. These parameters provide a platform for investors to compare various investments, by considering both profits and the risks involved. For Nippon India Pharma Fund, we have evaluated four risk-adjusted performance parameters.
    1. Top 25% Risk Adjusted Performance Parameters: The fund does not have any risk-adjusted performance parameters that are in the top 25% of the category.
    2. Above Average Below Top 25% Risk Adjusted Performance Parameters: The fund does not have any risk-adjusted performance parameters that are in the above average but below top 25% of the category.
    3. Below Average Risk Adjusted Performance Parameters: Nippon India Pharma Fund has four risk-adjusted performance parameters of the fund that are below average in the category.
      • Sharpe Ratio: Nippon India Pharma Fund has a Sharpe Ratio of 0.78 compared to the category average of 0.88.
      • Sterling Ratio: Nippon India Pharma Fund has a Sterling Ratio of 0.73 compared to the category average of 0.8.
      • Sortino Ratio: Nippon India Pharma Fund has a Sortino Ratio of 0.42 compared to the category average of 0.48.
      • Treynor Ratio: Nippon India Pharma Fund has a Treynor Ratio of 0.13 compared to the category average of 0.15.


Not able to see in mobile!!! save the chart by clicking on camera icon.

KPIs* Fund Benchmark Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % 2.41
2.88
-0.97 | 4.52 11 | 13 Average
3M Return % -0.77
-0.40
-9.73 | 3.09 10 | 13 Average
6M Return % 15.24
19.11
3.40 | 26.27 11 | 13 Average
1Y Return % 36.47
42.49
33.84 | 51.93 11 | 12 Poor
3Y Return % 20.90
22.41
19.56 | 25.88 6 | 8 Average
5Y Return % 27.67
28.25
24.23 | 30.74 5 | 8 Average
7Y Return % 20.24
19.20
18.29 | 20.24 1 | 4 Very Good
10Y Return % 15.44
14.16
13.17 | 15.44 1 | 3 Very Good
15Y Return % 18.00
17.36
16.05 | 18.05 2 | 3 Good
1Y SIP Return % -25.74
-21.85
-35.24 | -12.91 10 | 12 Poor
3Y SIP Return % 25.84
28.17
25.24 | 32.64 6 | 8 Average
5Y SIP Return % 23.71
24.81
21.75 | 27.67 7 | 8 Poor
7Y SIP Return % 23.30
23.68
23.30 | 24.58 4 | 4 Poor
10Y SIP Return % 19.11
18.45
17.90 | 19.11 1 | 3 Very Good
15Y SIP Return % 18.29
17.55
16.39 | 18.29 1 | 3 Very Good
Standard Deviation 15.23
15.42
14.47 | 16.13 4 | 8 Good
Semi Deviation 10.49
10.54
10.13 | 10.91 3 | 8 Good
Max Drawdown % -16.86
-16.50
-18.92 | -14.27 4 | 8 Good
VaR 1 Y % -14.68
-16.74
-18.91 | -14.68 1 | 8 Very Good
Average Drawdown % -5.70
-5.35
-6.76 | -4.22 6 | 8 Average
Sharpe Ratio 0.78
0.88
0.66 | 1.12 6 | 8 Average
Sterling Ratio 0.73
0.80
0.66 | 1.02 6 | 8 Average
Sortino Ratio 0.42
0.48
0.36 | 0.65 6 | 8 Average
Jensen Alpha % 2.57
4.05
0.12 | 8.16 6 | 8 Average
Treynor Ratio 0.13
0.15
0.11 | 0.19 6 | 8 Average
Modigliani Square Measure % 20.93
22.51
18.32 | 27.03 6 | 8 Average
Alpha % 0.83
2.41
-0.61 | 6.00 6 | 8 Average
Return data last Updated On : Dec. 20, 2024.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Nov. 29, 2024
KPIs: Key Performance Indicators

Rotate the phone! Best viewed in landscape mode on mobile.
KPIs* Fund Benchmark Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % 2.49 2.99 -0.84 | 4.64 11 | 13
3M Return % -0.54 -0.08 -9.36 | 3.54 10 | 13
6M Return % 15.76 19.88 4.26 | 27.36 11 | 13
1Y Return % 37.71 44.30 36.04 | 53.85 11 | 12
3Y Return % 21.99 23.89 21.29 | 27.00 6 | 8
5Y Return % 28.83 29.86 26.17 | 32.66 7 | 8
7Y Return % 21.31 20.56 19.50 | 21.68 2 | 4
10Y Return % 16.47 15.31 14.30 | 16.47 1 | 3
1Y SIP Return % -24.99 -20.75 -34.00 | -11.70 10 | 12
3Y SIP Return % 27.01 29.75 27.01 | 33.82 8 | 8
5Y SIP Return % 24.84 26.34 23.54 | 28.81 7 | 8
7Y SIP Return % 24.40 25.06 24.40 | 25.90 4 | 4
10Y SIP Return % 20.12 19.55 19.00 | 20.12 1 | 3
Standard Deviation 15.23 15.42 14.47 | 16.13 4 | 8
Semi Deviation 10.49 10.54 10.13 | 10.91 3 | 8
Max Drawdown % -16.86 -16.50 -18.92 | -14.27 4 | 8
VaR 1 Y % -14.68 -16.74 -18.91 | -14.68 1 | 8
Average Drawdown % -5.70 -5.35 -6.76 | -4.22 6 | 8
Sharpe Ratio 0.78 0.88 0.66 | 1.12 6 | 8
Sterling Ratio 0.73 0.80 0.66 | 1.02 6 | 8
Sortino Ratio 0.42 0.48 0.36 | 0.65 6 | 8
Jensen Alpha % 2.57 4.05 0.12 | 8.16 6 | 8
Treynor Ratio 0.13 0.15 0.11 | 0.19 6 | 8
Modigliani Square Measure % 20.93 22.51 18.32 | 27.03 6 | 8
Alpha % 0.83 2.41 -0.61 | 6.00 6 | 8
Return data last Updated On : Dec. 20, 2024.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Nov. 29, 2024
KPIs: Key Performance Indicators

Investment Period Regular Direct
Return % Current Value of ₹ 10000 Return % Current Value of ₹ 10000
1D -0.90 ₹ 9,910.00 -0.90 ₹ 9,910.00
1W 0.77 ₹ 10,077.00 0.79 ₹ 10,079.00
1M 2.41 ₹ 10,241.00 2.49 ₹ 10,249.00
3M -0.77 ₹ 9,923.00 -0.54 ₹ 9,946.00
6M 15.24 ₹ 11,524.00 15.76 ₹ 11,576.00
1Y 36.47 ₹ 13,647.00 37.71 ₹ 13,771.00
3Y 20.90 ₹ 17,670.00 21.99 ₹ 18,153.00
5Y 27.67 ₹ 33,919.00 28.83 ₹ 35,489.00
7Y 20.24 ₹ 36,340.00 21.31 ₹ 38,672.00
10Y 15.44 ₹ 42,036.00 16.47 ₹ 45,916.00
15Y 18.00 ₹ 119,703.00 ₹

Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.

Investment Period Invested Amount Regular Direct
XIRR % Current Value of Invested Amount XIRR % Current Value of Invested Amount
1Y ₹ 12000 -25.74 ₹ 10,252.26 -24.99 ₹ 10,305.22
3Y ₹ 36000 25.84 ₹ 52,348.21 27.01 ₹ 53,189.35
5Y ₹ 60000 23.71 ₹ 108,005.34 24.84 ₹ 110,999.10
7Y ₹ 84000 23.30 ₹ 192,717.00 24.40 ₹ 200,401.49
10Y ₹ 120000 19.11 ₹ 328,502.40 20.12 ₹ 346,905.36
15Y ₹ 180000 18.29 ₹ 822,732.84 ₹


Date Nippon India Pharma Fund NAV Regular Growth Nippon India Pharma Fund NAV Direct Growth
20-12-2024 512.9617 568.3789
19-12-2024 517.6108 573.5163
18-12-2024 512.4279 567.7596
17-12-2024 506.9959 561.7272
16-12-2024 509.6395 564.6423
13-12-2024 509.027 563.9219
12-12-2024 511.1866 566.3005
11-12-2024 513.7142 569.0866
10-12-2024 512.8907 568.1604
09-12-2024 513.417 568.7293
06-12-2024 516.8703 572.5123
05-12-2024 517.9598 573.7048
04-12-2024 518.1993 573.956
03-12-2024 516.3408 571.8835
02-12-2024 515.9282 571.4124
29-11-2024 510.8149 565.7073
28-11-2024 501.0993 554.934
27-11-2024 503.3565 557.4199
26-11-2024 506.3882 560.7635
25-11-2024 510.493 565.295
22-11-2024 506.5908 560.9325
21-11-2024 500.8806 554.5961

Fund Launch Date: 10/May/2004
Fund Category: Pharma Fund
Investment Objective: The Fund seeks to invest in pharma sector with focus on important segments of the sector viz Domestic Business, International & CRAMS and include deep value as well as high growth pharma businesses. The fund invests across market capitalization within the sector. It may suit investment horizon of around 2-3 years
Fund Description: An open ended equity scheme investing in pharma sector
Fund Benchmark: S&P BSE Healthcare TR
Source: Fund FactSheet

Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.